In April, members of Geneva’s Scientific Advisory Board (SAB), Board Chair Major General Frank Scoggins, President & CEO Elise Huszar, and Senior Marketing & Communications Manager Allison Connelly traveled to the National Capital Region for the Annual SAB Meeting. The visit enabled SAB members to continue their impressive support and advocacy of the organization with
Thank you Budget and Contract Manager Shawn Potts, for your outstanding service and dedication to Geneva’s core values and mission! An excerpt from her nomination states: “Shawn leads both by example and by teamwork, allowing others to grow in a supportive environment. She will take the lead on a project when needed, but is also
Geneva Client Relationship Manager Jennifer Johnson and Technical Reviewer Iori Ueki will be exhibiting at booth 1126 at the upcoming SOMSA event, on 6-10 May. SOMSA, hosted by the Special Operations Medical Association (SOMA), will take place at the Charlotte Convention Center in Charlotte, North Carolina. This event provides the opportunity for military and civilian
On 15 April, Geneva celebrated it’s 26th year as foundation. From a non-profit of two volunteers to a successful organization with approximately 500 employees, Geneva has remained dedicated to our mission of advancing innovative medical research across the globe. Since its inception, Geneva’s employees and researchers have supported and spearheaded research programs at military treatment
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), in collaboration with Geneva and Gilead Sciences, Inc., has announced that the U.S. Food and Drug Administration (FDA) has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus (EBOV) infections. USAMRIID
Thanks to a generous contribution from the LT Murray Family Foundation, Geneva is pleased to announce the first small grant competition for researchers at Joint Base Lewis-McChord! Geneva’s Scientific Advisory Board will be evaluating project proposals that are related to military medical research and are either pilot projects that enable the researcher to collect preliminary
Geneva’s Board of Directors recently elected Major General (Ret.) Frank Scoggins as its new Chair. Having served on Geneva’s Board since 2011, Major General Scoggins has demonstrated an active engagement in the success and growth of the organization’s mission, programmatic growth, and long-term financial sustainability. Major General Scoggins retired from the U.S. Air Force (USAF)
Geneva is pleased to announce the addition of Dr. Kenneth Bertram to the Board of Directors. Dr. Kenneth A. Bertram is the Clinical Product Development Officer for the Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC. In this position, he leads a team conducting early clinical trials using human stem cells to regulate the body’s
The Uniformed Services University (USU) recently issued a Cooperative agreement to Geneva to facilitate the execution of the Collaboratory for Musculoskeletal Injury Rehabilitation Research (CMIRR). CMIRR is a four-year, $15M program funded by the Defense Health Agency (DHA), with the purpose of improving a rehabilitative approach to caring for military service members with musculoskeletal injury